Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 1.00 |
| ▸ | LMNA | P02545 | 3/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.77 |
| ▸ | POLB | P06746 | 1/20 | 0.77 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | SREBF2 | Q12772 | 10/20 | 0.40 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | ATM | Q13315 | 3/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | NOS2 | P35228 | 1/20 | 0.36 |
| ▸ | KDM5A | P29375 | 1/20 | 0.36 |
| ▸ | KDM5C | P41229 | 1/20 | 0.36 |
| ▸ | KDM5D | Q9BY66 | 1/20 | 0.36 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.36 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Protionamide SCHEMBL30271512 | 1.00 | KDM4E (1.00) | KDM4ELMNACYP3A4TSHRCYP1A2 | |
| SCHEMBL28093033 | 0.92 | KDM4E (0.84) | KDM4ELMNACYP3A4TSHRCYP1A2 | |
| SCHEMBL10491662 | 0.87 | KDM4E (0.77) | KDM4ELMNACYP3A4TSHRCYP1A2 | |
| Ethionamide SCHEMBL12264084 | 0.87 | CYP1A2 (1.00) | KDM4ELMNACYP3A4TSHRCYP1A2 | |
| Ethionamide SCHEMBL12264093 | 0.87 | CYP1A2 (1.00) | KDM4ELMNACYP3A4TSHRCYP1A2 | |
| Ethionamide SCHEMBL27007 | 0.87 | CYP1A2 (1.00) | KDM4ELMNACYP3A4TSHRCYP1A2 | |
| Ethionamide SCHEMBL12264091 | 0.87 | CYP1A2 (1.00) | KDM4ELMNACYP3A4TSHRCYP1A2 | |
| Ethionamide SCHEMBL12264086 | 0.87 | CYP1A2 (1.00) | KDM4ELMNACYP3A4TSHRCYP1A2 | |
| Ethionamide SCHEMBL12264090 | 0.87 | CYP1A2 (1.00) | KDM4ELMNACYP3A4TSHRCYP1A2 | |
| Ethionamide SCHEMBL12264085 | 0.87 | CYP1A2 (1.00) | KDM4ELMNACYP3A4TSHRCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3302 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260137766-A1 | LIPOSOME FORMULATIONS FOR TREATMENT OF ACTIVE TUBERCULOSIS | ARCHIVEL FARMA S L (ES) | 2026-05-21 | — | — | US | claimed |
| EP-4736841-A1 | A MUCOADHESIVE LAYER FOR BUCCAL ADMINISTRATION OF AN ACTIVE PHARMACEUTICAL INGREDIENT | IQ medical GmbH (DE) | 2026-05-06 | — | — | EP | claimed |
| EP-4727950-A1 | HETEROCYCLIC COMPOUNDS AND THEIR USE IN THE TREATMENT OF MYCOBACTERIAL INFECTIONS | GlaxoSmithKline Intellectual Property Development Ltd (GB) | 2026-04-22 | — | — | EP | claimed |
| EP-4121058-B1 | OXAZOLIDINONE COMPOUND AND ITS USE THEREOF AS AN ANTIBACTERIAL AGENT | MERCK SHARP & DOHME LLC (US) | 2026-02-18 | — | — | EP | claimed |
| US-20260035363-A1 | COMPOUNDS AND METHODS OF USE THEREOF AS ANTIBACTERIAL AGENTS | MERCK SHARP & DOHME LLC (US) | 2026-02-05 | — | — | US | claimed |
| EP-4674846-A1 | UREA MOTIF CONTAINING COMPOUNDS AS ANTIBACTERIAL DRUGS AGAINST MULTIRESISTANT MYCOBACTERIA | Technische Universität München (DE) | 2026-01-07 | — | — | EP | claimed |
| US-12459933-B2 | Compounds and methods of use thereof as antibacterial agents | MERCK SHARP & DOHME LLC (US) | 2025-11-04 | — | — | US | claimed |
| US-12435077-B2 | Oxazolidinone compound and methods of use thereof as an antibacterial agent | MERCK SHARP & DOHME LLC (US) | 2025-10-07 | — | — | US | claimed |
| EP-4601620-A1 | LIPOSOME FORMULATIONS FOR TREATMENT OF ACTIVE TUBERCULOSIS | Archivel Farma, S.l. (ES) | 2025-08-20 | — | — | EP | claimed |
| US-12365656-B2 | Oxazolidinone compounds and methods of use thereof as antibacterial agents | MERCK SHARP & DOHME LLC (US) | 2025-07-22 | — | — | US | claimed |
| WO-2001044272-A2 | DAPTOMYCIN ANALOGS AS ANTIBACTERIAL AGENTS | CUBIST PHARMACEUTICALS, INC. (US) | 2001-06-21 | — | — | WO | claimed |
| WO-2001044274-A1 | LIPOPEPTIDES AS ANTIBACTERIAL AGENTS | CUBIST PHARMACEUTICALS, INC. (US) | 2001-06-21 | — | — | WO | claimed |
| WO-2001044271-A2 | DAPTOMYCIN ANALOGS AND THEIR USE AS ANTIBACTERIAL AGENTS | CUBIST PHARMACEUTICALS, INC. (US) | 2001-06-21 | — | — | WO | claimed |
| CN-1297352-A | Use of organophosphorous compounds for the therapeutic and prophylactic treatment of infections | HASSAN JOMAA (DE) | 2001-05-30 | — | — | CN | claimed |
| CN-1264430-A | Betaines as adjuvants to susceptibility testing and antimicrobial therapy | INTEGRATED RES TECHNOLOGY PLC (US) | 2000-08-23 | — | — | CN | claimed |
| US-6054133-A | Anti-microbial targeting for intracellular pathogens | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2000-04-25 | — | — | US | claimed |
| WO-2000018419-A2 | METHODS FOR ADMINISTRATION OF ANTIBIOTICS | CUBIST PHARMACEUTICALS, INC. (US) | 2000-04-06 | — | — | WO | claimed |
| EP-0980438-A1 | BETAINES AS ADJUDVANTS TO SUSCEPTIBILITY TESTING AND ANTIMICROBIAL THERAPY | Integrated Research Technology, LLC (US) | 2000-02-23 | — | — | EP | claimed |
| WO-1998050576-A1 | BETAINES AS ADJUVANTS TO SUSCEPTIBILITY TESTING AND ANTIMICROBIAL THERAPY | INTEGRATED RESEARCH TECHNOLOGY, LLC (US) | 1998-11-12 | — | — | WO | claimed |
| US-4005207-A | ISONICOTINIC ACID HYDRAZIDE, 2-PROPYL THIO-ISONICOTINAMIDE, 4,4'-DIAMINODIPHENYL SULFONE | SAARSTICKSTOFF-FATOL GMBH (DT) | 1977-01-25 | — | — | US | claimed |